External resources PubMed: Allodynia (skin tenderness) associated with semaglutide case series PMC: Allodynia and dysesthesia associated with semaglutide and tirzepatide For researchers seeking comprehensive, evidence-based guidance on GLP-1 medications, side effect management, and peptide safety , SeekPeptides provides the most thorough resource available, with regularly updated protocols, detailed guides, and a community of experienced researchers who have navigated these exact questions
Lilly announced that ATTAIN-3 was the third successful Phase 3 trial, triggering global regulatory submissions for obesity in 2025
These physical characteristics are harder to replicate than packaging alone
A recent small study found that reduced GLP-1 frequency may help people maintain their weight loss
The GLP-1 Insurance Coverage Checker dramatically simplifies this process." The GLP-1 Coverage Checker is Ro's latest effort to build tools and resources that help patients more easily access the weight loss treatment they need to effectively achieve their goals
doi: 10.1111/j.1463-1326.2009.01154.x
